INTERNATIONAL PATENT: ALCON INC. FILES APPLICATION FOR "UTILIZATION OF NANOPARTICLES IN TARGETED THERAPY"

GENEVA, Aug. 4 -- ALCON INC. (Rue Louis-d'Affry 61701 Fribourg) filed a patent application (PCT/IB2025/050660) for "UTILIZATION OF NANOPARTICLES IN TARGETED THERAPY" on Jan 22, 2025. With publication no. WO/2025/158297, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HALLEN, Paul R. (c/o Alcon Vision, LLC6201 South FreewayFort Worth, Texas 76134)

Abstract: Methods for targeted therapy are disclosed. In certain embodiments, a method includes injecting nanoparticles into a target site in or adjacent to an eye, irradiatin...